Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Vigil Neuroscience, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 52
- −5 vs. Q2 2024
- Shares held
- 27.7M
- +2.00M (+7.8%) vs. Q2 2024
- Total value
- $94.2M
- −$8.67M (−8.4%) vs. Q2 2024
- New holders
- 11
- 12 more added
- Sold out
- 16
- 18 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 (DIFC) Ltd | 7 | $24 | 0.00% | −5,499−99.9% | Reduced |
| Morgan Stanley | 11 | $37 | 0.00% | −19,830−99.9% | Reduced |
| Nisa Investment Advisors, LLC | 45 | $153 | 0.00% | −30−40.0% | Reduced |
| Federated Hermes, Inc. | 198 | $673 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 283 | $962 | 0.00% | −4,525−94.1% | Reduced |
| JPMorgan Chase & Co | 414 | $1.41K | 0.00% | −8,723−95.5% | Reduced |
| Royal Bank of Canada | 471 | $2.00K | 0.00% | −19,984−97.7% | Reduced |
| FMR LLC | 2,086 | $7.09K | 0.00% | −810−28.0% | Reduced |
| Tower Research Capital LLC (TRC) | 3,512 | $11.9K | 0.00% | −8,253−70.1% | Reduced |
| Catalyst Funds Management Pty Ltd | 4,100 | $13.9K | 0.00% | 00.0% | Unchanged |
| Jump Financial, LLC | 10,000 | $34.0K | 0.00% | +10,000 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 11,687 | $39.7K | 0.01% | −10,167−46.5% | Reduced |
| Cubist Systematic Strategies, LLC | 15,762 | $53.6K | 0.00% | +12,109+331.5% | Added |
| American Century Companies Inc | 19,970 | $67.9K | 0.00% | +19,970 | New |
| Two Sigma Advisers, LP | 20,100 | $68.3K | 0.00% | +20,100 | New |
| ADAR1 Capital Management, LLC | 21,737 | $73.9K | 0.01% | +21,737 | New |
| Bank of America Corp | 23,463 | $79.8K | 0.00% | −3,334−12.4% | Reduced |
| Sherbrooke Park Advisers LLC | 26,329 | $89.5K | 0.02% | +26,329 | New |
| State Street Corp | 40,739 | $138.5K | 0.00% | 00.0% | Unchanged |
| PEAK6 Investments LLC | 41,486 | $141.1K | 0.01% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 42,585 | $144.8K | 0.00% | +12,156+39.9% | Added |
| Barclays PLC | 44,613 | $151.7K | 0.00% | −142−0.3% | Reduced |
| Renaissance Technologies LLC | 46,000 | $156.4K | 0.00% | −25,500−35.7% | Reduced |
| Citigroup Inc | 48,383 | $164.5K | 0.00% | +45,972+1,906.8% | Added |
| Northern Trust Corp | 50,165 | $170.6K | 0.00% | −83,438−62.5% | Reduced |
| Two Sigma Investments, LP | 95,084 | $323.3K | 0.00% | +83,019+688.1% | Added |
| Bridgeway Capital Management, LLC | 105,064 | $357.2K | 0.01% | +25,000+31.2% | Added |
| Walleye Capital LLC | 119,792 | $407.3K | 0.00% | +92,217+334.4% | Added |
| Verition Fund Management LLC | 130,030 | $442.1K | 0.00% | +130,030 | New |
| Marshall Wace, LLP | 144,042 | $489.7K | 0.00% | +144,042 | New |
| Woodline Partners LP | 144,142 | $490.1K | 0.00% | −62,472−30.2% | Reduced |
| Geode Capital Management, LLC | 226,083 | $768.8K | 0.00% | +66,712+41.9% | Added |
| Standard Life Aberdeen plc | 235,011 | $799.0K | 0.00% | +235,011 | New |
| Millennium Management LLC | 278,756 | $947.8K | 0.00% | −56,051−16.7% | Reduced |
| ArrowMark Colorado Holdings LLC | 289,460 | $984.2K | 0.01% | 00.0% | Unchanged |
| BlackRock, Inc. | 422,547 | $1.44M | 0.00% | +422,547 | New |
| OrbiMed Advisors LLC | 448,891 | $1.53M | 0.03% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $1.60M | 0.05% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $1.91M | 1.13% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 605,536 | $2.06M | 0.00% | +210,420+53.3% | Added |
| StemPoint Capital LP | 743,719 | $2.53M | 0.76% | −693−0.1% | Reduced |
| Vanguard Group Inc | 904,731 | $3.08M | 0.00% | +90,000+11.0% | Added |
| 683 Capital Management, LLC | 1,219,580 | $4.15M | 0.42% | +119,580+10.9% | Added |
| Citadel Advisors LLC | 1,442,468 | $4.90M | 0.01% | −6910.0% | Reduced |
| Deep Track Capital, LP | 1,553,996 | $5.28M | 0.17% | +956,781+160.2% | Added |
| Point72 Asset Management, L.P. | 1,600,000 | $5.44M | 0.02% | +115,000+7.7% | Added |
| Sphera Funds Management Ltd. | 1,647,604 | $5.60M | 0.92% | −44,562−2.6% | Reduced |
| BVF Inc | 1,813,633 | $6.17M | 0.18% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,991,038 | $6.77M | 0.34% | +1,991,038 | New |
| Northpond Ventures, LLC | 4,214,498 | $14.3M | 32.82% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $19.8M | 1.84% | 00.0% | Unchanged |
| Gotham Asset Management, LLC | 5,933 | – | – | +5,933 | New |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,828,691−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −401,139−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −62,354−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −48,051−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −44,893−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −38,364−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −32,800−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −16,609−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,867−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −8,135−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −6,598−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −2,588−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −2,029−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −831−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |